Healthcare and Life Science
Approaching the final frontier: Are we in a golden decade of drug development for the central nervous system?
In this CRA Insights, the authors Will Foster, Kees Chamberlain, Joanne Clark, and Carl Lottig recount the recent scientific and technological advances in drug development in the central nervous system (CNS). CNS disorders impose a significant burden on patients, with the global im...
Fertility needs to be the next big conversation for the workplace
“Women can have it all, but they can’t do it all themselves,” observes Dr Shreeya Tewary, Bourn Hall Consultant Gynaecologist and IVF Specialist, ahead of the Rising Festival, in Cambridge on 21 September 2024, which will be celebrating women’s ‘potential, ambition, fulfilment and wellb...
Connect: Health Tech – ‘the connectivity mix’ visual branding
For this thought leadership project ‘The connectivity mix’ we needed to create the brand for the Ecosystem Insights that can be used for all in-depth papers and short articles. Still using the Connect: Health Tech colours, images, icons and hashtags to tie into the overall look and feel...
Arecor presents positive data from phase I clinical trial of ultra-concentrated ultra-rapid acting insulin AT278
- AT278 delivers significantly accelerated early PK/PD profile compared with NovoRapid® in people with Type 2 Diabetes and high BMI - Results confirm previous findings in people with Type 1 diabetes and show that AT278 can maintain the faster action p...
Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors
Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine learning, and personalized dosing to enhance dr...
Cellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation ...
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs
Appointment brings extensive regulatory experience as lead asset ETD001 progresses through Phase 2 clinical trial for treatment of cystic fibrosis Brighton, UK, 11 September 2024: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and devel...
Engagement and motivation at work: what's the difference?
At work, you’ve probably heard people throwing around the terms “motivation” and “engagement” like they’re the same thing. Spoiler alert: They’re not. While both are crucial for driving employee performance and satisfaction, they represent distinct aspects of how we experience the workp...
Health Innovation East and 42T webinar to help power Net Zero NHS
Health Innovation East, the innovation arm of the NHS in the East of England and 42 Technology (42T), a product design and innovation consultancy, are co-hosting a free webinar aimed at helping the NHS achieve its ambitious net zero goals. ...
PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Manageme...